ArticleAdvanced healthcare materials2026
Hybrid Nanofibers for Multimodal Accelerated Wound Healing.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Wound healing is a complex physiological process that demands multifunctional therapeutic approaches to ensure effective recovery. This study presents a straightforward approach using blend electrospinning to produce multimodal hybrid nanomaterials that accelerate the wound healing process. Poly(L-lactide-co-ε-caprolactone) (PLCL), cellulose acetate (CA), and polyethylene oxide (PEO) were utilized as biodegradable, compatible, and compliant polymers for generating nanofibers. Hybrid nanofibers functionalized with dexamethasone, ascorbic acid, and hyperbranched polymers introduce anti-inflammatory, regenerative, and antimicrobial properties. Pristine nanofibers with diameters of 0.818 ± 0.028 and 0.845 ± 0.039 µm were generated, while drug-loaded fibers with average diameters of 1.075 ± 0.055 and 1.235 ± 0.075 µm were obtained. The fibers demonstrated a porosity ranging from 72 % to 86 %. Further, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), thermogravimetric analysis (TGA), and contact angle, as well as zeta potential measurements, highlight the physicochemical properties of the fibers. In vivo studies of the nanofibers demonstrated that by day 11, there was a significant acceleration in wound healing. A remarkable acceleration was observed in cell proliferation, granulation, and remodeling phases. The findings emphasize the potential of multimodal hybrid nanofibers as advanced wound dressings and the importance of integrative strategies in wound care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.